Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Full seroconversion in initial non-responders with higher antibody levels after heterologous COVID-19 vaccination schedule.

Angelika Wagner,Anna Ohradanova-Repic,Laura Gebetsberger,Gabor Tajti,Michael Kundi,Hannes Stockinger,Ursula Wiedermann,Katharina Grabmeier-Pfistershammer

Immunology Letters（2022）

Cited 1|Views12
No score
Abstract
•5% non-responder and 3.4% low-responder rate after the first dose of ChAdOx1.•All seroconverted after the second dose and no non-responders.•Higher antibody levels after a heterologous second dose with mRNA-1273.
More
Translated text
Key words
COVID-19,Vaccination strategy,Humoral immune response,Initial non/low responder,Heterologous COVID-19 vaccine schedule,Antibody testing
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined